Skip to content

Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia

A Culturally Based Family Therapy for Schizophrenia

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00356317
Enrollment
400
Registered
2006-07-25
Start date
2015-03-31
Completion date
2015-03-31
Last updated
2015-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Keywords

Culture, Family, Therapy

Brief summary

This study will evaluate the effectiveness of a culturally based family therapy intervention in improving treatment outcome in people with schizophrenia.

Detailed description

Schizophrenia is a disabling mental disorder that affects approximately 1% of the population worldwide. People with schizophrenia frequently experience hallucinations, delusions, disordered thinking, movement disorders, emotional numbness, social withdrawal, and cognitive deficits. These symptoms can hinder a person's ability to perform everyday functions, such as hold a job and maintain normal social relationships. When combined with medication, family-oriented therapy interventions have been beneficial for people with schizophrenia. There are few programs, however, that are tailored to the needs of minorities. With the rising number of minority populations in the U.S., it is important to develop psychotherapy interventions that are designed specifically for these groups. This study will evaluate the effectiveness of a culturally based family therapy intervention in improving treatment outcome in people with schizophrenia. Participants in this 12-month, open label study will first attend a 2-hour screening visit, at which information will be gathered regarding coping styles, spirituality, and expressed emotion. Participants will then be randomly assigned to receive either culturally based therapy or treatment as usual. Although the culturally based therapy will be tailored to the needs and values of Hispanics, people who are not Hispanic will not be excluded. The culturally based therapy will entail 15 weekly therapy sessions, which will focus on family unity, psychoeducation, spirituality, communication skills, and problem-solving. The group receiving treatment as usual will attend 3 weekly psychoeducation sessions that will focus on informing participants about schizophrenia. Outcomes for both groups will be assessed upon completion of treatment and at follow-up visits at Months 6 and 12.

Interventions

BEHAVIORALCulturally informed therapy for schizophrenia (CIT-S)

This family therapy consists of 15 video-taped, therapy sessions, each lasting approximately 75 minutes. The 15-session treatment will be broken down into five segments (each lasting approximately three sessions) with the following goals: 1) Fortify a strong sense of family unity; 2) educate about schizophrenia; 3) foster adaptive use of cultural, spiritual and/or existential beliefs in conceptualizing and coming to terms with schizophrenia; 4) teach effective communication training techniques; and 5) and teach useful problem solving strategies.

BEHAVIORALPsychoeducation treatment as usual

This family therapy consists of three weekly sessions focusing on education about schizophrenia.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

For participants with schizophrenia or schizoaffective disorder: * Diagnosis of schizophrenia or schizoaffective disorder * Currently taking medication * 18 or older For all participants: * Two or more family members, including patient, are available for participation (therapy can be conducted if patient is not available, as long as two other family members are interested in participating) * Family members must be at least 13 years old

Exclusion criteria

* N/A

Design outcomes

Primary

MeasureTime frame
Schizophrenia symptom severityMeasured immediately post-treatment and at Months 6 and 12

Secondary

MeasureTime frame
Family functioningMeasured immediately post-treatment and at Months 6 and 12
Cultural IdentityMeasured immediately post-treatment and at Months 6 and 12
Coping stylesMeasured immediately post-treatment and at Months 6 and 12
Symptoms of depression, anxiety, and stressMeasured immediately post-treatment and at Months 6 and 12
Alcohol and Drug UseMeasured immediately post-treatment and at Months 6 and 12
Knowledge and knowledge about schizophreniaMeasured immediately post-treatment and at Months 6 and 12
Religiosity/SpiritualityMeasured immediately post-treatment and at Months 6 and 12

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026